甜甜小的个人主页 - 老虎社区

甜甜小

甜甜小

暂无个人介绍

IP属地：未知

0关注

0粉丝

0主题

0勋章

08-15

$BOSS直聘-W(02076)$ $BOSS直聘(BZ)$ 从行业前景到企业自身经营数据，多维度呈现向好态势，BOSS直聘的成长逻辑有很强的可验证性

07-31

$极智嘉-W(02590)$ 极智嘉获YesAsia复购，成为香港规模最大的 AMR机器人智能仓，我不信业务增长你股价能一直跌。

07-08

$云知声(09678)$ 上次跌到300块我果断加仓，感谢自己没被洗下车，这波看到500港元

06-11

发现现在药企都在卷双抗，维立志博这个PD-L1/4-1BB双抗是全球首个进注册临床的4-1BB靶向药，先发已经优势有了

06-10

在创新药投资中，高风险常被挂在嘴边，看了下维立志博的几个管线，安全性优势很突出，这对后续商业化至关重要，毕竟医生更愿意用副作用小的药，在管线布局上，也都踩在临床刚需和竞争较少的痛点上，这点还是不错的

04-22

老厉害了

@静待花开的小C:我开仓了$三倍做多半导体ETF-Direxion Daily(SOXL)$ ,半导体调整太大，英伟达也扛不住。这个位置买入风险没这么大了。

04-18

[贱笑]

@躺平指数:AI没落？台积电业绩力证繁荣仍在，却难扫关税阴霾

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4130491029501360","uuid":"4130491029501360","gmtCreate":1667387938529,"gmtModify":1744099372161,"name":"甜甜小","pinyin":"ttxtiantianxiao","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/25fc231df4362a5cdc318177a8de3233","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":0,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":2,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":467892285927640,"gmtCreate":1755249073740,"gmtModify":1755249075004,"author":{"id":"4130491029501360","authorId":"4130491029501360","name":"甜甜小","avatar":"https://static.tigerbbs.com/25fc231df4362a5cdc318177a8de3233","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4130491029501360","authorIdStr":"4130491029501360"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02076\">$BOSS直聘-W(02076)$</a> <a href=\"https://laohu8.com/S/BZ\">$BOSS直聘(BZ)$</a> 从行业前景到企业自身经营数据，多维度呈现向好态势，BOSS直聘的成长逻辑有很强的可验证性","listText":"<a href=\"https://laohu8.com/S/02076\">$BOSS直聘-W(02076)$</a> <a href=\"https://laohu8.com/S/BZ\">$BOSS直聘(BZ)$</a> 从行业前景到企业自身经营数据，多维度呈现向好态势，BOSS直聘的成长逻辑有很强的可验证性","text":"$BOSS直聘-W(02076)$ $BOSS直聘(BZ)$ 从行业前景到企业自身经营数据，多维度呈现向好态势，BOSS直聘的成长逻辑有很强的可验证性","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/467892285927640","isVote":1,"tweetType":1,"viewCount":140,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":462469567807920,"gmtCreate":1753926472111,"gmtModify":1753926951180,"author":{"id":"4130491029501360","authorId":"4130491029501360","name":"甜甜小","avatar":"https://static.tigerbbs.com/25fc231df4362a5cdc318177a8de3233","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4130491029501360","authorIdStr":"4130491029501360"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02590\">$极智嘉-W(02590)$</a> 极智嘉获YesAsia复购，成为香港规模最大的 AMR机器人智能仓，我不信业务增长你股价能一直跌。","listText":"<a href=\"https://laohu8.com/S/02590\">$极智嘉-W(02590)$</a> 极智嘉获YesAsia复购，成为香港规模最大的 AMR机器人智能仓，我不信业务增长你股价能一直跌。","text":"$极智嘉-W(02590)$ 极智嘉获YesAsia复购，成为香港规模最大的 AMR机器人智能仓，我不信业务增长你股价能一直跌。","images":[{"img":"https://static.tigerbbs.com/2225a737cfd9e6798ca05d3cc4b8132e","width":"1236","height":"597"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/462469567807920","isVote":1,"tweetType":1,"viewCount":405,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":454284342829264,"gmtCreate":1751939808749,"gmtModify":1751939820048,"author":{"id":"4130491029501360","authorId":"4130491029501360","name":"甜甜小","avatar":"https://static.tigerbbs.com/25fc231df4362a5cdc318177a8de3233","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4130491029501360","authorIdStr":"4130491029501360"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/09678\">$云知声(09678)$</a> 上次跌到300块我果断加仓，感谢自己没被洗下车，这波看到500港元","listText":"<a href=\"https://laohu8.com/S/09678\">$云知声(09678)$</a> 上次跌到300块我果断加仓，感谢自己没被洗下车，这波看到500港元","text":"$云知声(09678)$ 上次跌到300块我果断加仓，感谢自己没被洗下车，这波看到500港元","images":[{"img":"https://static.tigerbbs.com/3c8a7d3e2f3eabe69efd62831322f2b2","width":"1080","height":"2376"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/454284342829264","isVote":1,"tweetType":1,"viewCount":405,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":444780383171168,"gmtCreate":1749610019172,"gmtModify":1749610020907,"author":{"id":"4130491029501360","authorId":"4130491029501360","name":"甜甜小","avatar":"https://static.tigerbbs.com/25fc231df4362a5cdc318177a8de3233","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4130491029501360","authorIdStr":"4130491029501360"},"themes":[],"htmlText":"发现现在药企都在卷双抗，维立志博这个PD-L1/4-1BB双抗是全球首个进注册临床的4-1BB靶向药，先发已经优势有了","listText":"发现现在药企都在卷双抗，维立志博这个PD-L1/4-1BB双抗是全球首个进注册临床的4-1BB靶向药，先发已经优势有了","text":"发现现在药企都在卷双抗，维立志博这个PD-L1/4-1BB双抗是全球首个进注册临床的4-1BB靶向药，先发已经优势有了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/444780383171168","isVote":1,"tweetType":1,"viewCount":447,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":444462053658920,"gmtCreate":1749532544797,"gmtModify":1749533016597,"author":{"id":"4130491029501360","authorId":"4130491029501360","name":"甜甜小","avatar":"https://static.tigerbbs.com/25fc231df4362a5cdc318177a8de3233","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4130491029501360","authorIdStr":"4130491029501360"},"themes":[],"htmlText":"在创新药投资中，高风险常被挂在嘴边，看了下维立志博的几个管线，安全性优势很突出，这对后续商业化至关重要，毕竟医生更愿意用副作用小的药，在管线布局上，也都踩在临床刚需和竞争较少的痛点上，这点还是不错的","listText":"在创新药投资中，高风险常被挂在嘴边，看了下维立志博的几个管线，安全性优势很突出，这对后续商业化至关重要，毕竟医生更愿意用副作用小的药，在管线布局上，也都踩在临床刚需和竞争较少的痛点上，这点还是不错的","text":"在创新药投资中，高风险常被挂在嘴边，看了下维立志博的几个管线，安全性优势很突出，这对后续商业化至关重要，毕竟医生更愿意用副作用小的药，在管线布局上，也都踩在临床刚需和竞争较少的痛点上，这点还是不错的","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/444462053658920","isVote":1,"tweetType":1,"viewCount":468,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":427196267896928,"gmtCreate":1745319812685,"gmtModify":1745326603450,"author":{"id":"4130491029501360","authorId":"4130491029501360","name":"甜甜小","avatar":"https://static.tigerbbs.com/25fc231df4362a5cdc318177a8de3233","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4130491029501360","authorIdStr":"4130491029501360"},"themes":[],"htmlText":"老厉害了","listText":"老厉害了","text":"老厉害了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/427196267896928","repostId":"427088858517752","repostType":1,"repost":{"id":427088858517752,"gmtCreate":1745292934673,"gmtModify":1746577348014,"author":{"id":"3586209944041237","authorId":"3586209944041237","name":"静待花开的小C","avatar":"https://static.tigerbbs.com/4befb19561784346ee300c191ae4c5f2","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586209944041237","authorIdStr":"3586209944041237"},"themes":[],"htmlText":"我开仓了<a href=\"https://laohu8.com/S/SOXL\">$三倍做多半导体ETF-Direxion Daily(SOXL)$&nbsp;</a>,半导体调整太大，英伟达也扛不住。这个位置买入风险没这么大了。","listText":"我开仓了<a href=\"https://laohu8.com/S/SOXL\">$三倍做多半导体ETF-Direxion Daily(SOXL)$&nbsp;</a>,半导体调整太大，英伟达也扛不住。这个位置买入风险没这么大了。","text":"我开仓了$三倍做多半导体ETF-Direxion Daily(SOXL)$ ,半导体调整太大，英伟达也扛不住。这个位置买入风险没这么大了。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/427088858517752","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":910,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":425753291084000,"gmtCreate":1744966867999,"gmtModify":1744966948024,"author":{"id":"4130491029501360","authorId":"4130491029501360","name":"甜甜小","avatar":"https://static.tigerbbs.com/25fc231df4362a5cdc318177a8de3233","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4130491029501360","authorIdStr":"4130491029501360"},"themes":[],"htmlText":"[贱笑]","listText":"[贱笑]","text":"[贱笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/425753291084000","repostId":"425736670114544","repostType":1,"repost":{"id":425736670114544,"gmtCreate":1744963445907,"gmtModify":1744964286404,"author":{"id":"3526437230772528","authorId":"3526437230772528","name":"躺平指数","avatar":"https://static.tigerbbs.com/c500a27501e73e9bde05437de1974e50","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3526437230772528","authorIdStr":"3526437230772528"},"themes":[],"title":"AI没落？台积电业绩力证繁荣仍在，却难扫关税阴霾","htmlText":"最近这一个月，你周围有多少投资者还高频关注AI？想必已所剩无几了吧。 在那个疯狂的特朗普开始向全世界“征税”之后，全球股市的涨跌几乎只系于一人之言，什么AI应用、比特币等等，这些盛极一时的题材无论基本面如何，该跌的时候是几乎没有底线。在这种状况下，市场变成了“赌场”，虽然遍地都是交易的机会，动不动百分之十几的震荡，赚钱的难度远高于以往。 就在这个市场唯一主题是特朗普推特的时候，台积电召开了2025Q1业绩会，向整个美股传达了坚定的信念： AI带来的基本面大繁荣没有消散。 据台积电预计，2025年全年公司以美元计算的增速为25%，仍然维持在“关税战”爆发前所预测的水平；Q2公司的收入将会受益于3nm和5nm制程工艺的强劲增长，达到284亿美元至292亿美元之间，环比增速将达到13%，同比增速约40%，大幅超越华尔街的一致预期。 这种乐观的预期和心态，和现如今风雨飘摇的全球市场形成了格外鲜明的对比。甚至，在特朗普关税开始征收之前，当Deepseek横空出世之后，市场就开始怀疑微软、谷歌这些巨头是否会在2025年缩减购买英伟达高算力芯片的预算，而英伟达正是台积电继苹果之后的最大客户，一旦英伟达收入被影响，会直接拉低台积电的业绩。 公司CEO则在业绩会上明确表示，公司明白关税政策的潜在影响存在不确定性和风险，可到目前为止还没有看到客户行为有任何变化。但在我们看来，无论高管说什么都不重要，现在的市场关键还是关税，即便是台积电自己的业绩，也极大依赖于特朗普未来的选择。 现实情况是，特朗普针对中国特供的H20芯片禁令加码，对于英伟达生产的H20芯片以及达到H20内存带宽、互联带宽的其他芯片，若出口到中国等国家和地区需要获得许可证，且该许可证要求将无限期生效。 北京时间4月17日下午，英伟达CEO黄仁勋来到北京，开启他的系列访问，这是短短四个月内他第二次来到中国。和上一次全程松弛相比，这次","listText":"最近这一个月，你周围有多少投资者还高频关注AI？想必已所剩无几了吧。 在那个疯狂的特朗普开始向全世界“征税”之后，全球股市的涨跌几乎只系于一人之言，什么AI应用、比特币等等，这些盛极一时的题材无论基本面如何，该跌的时候是几乎没有底线。在这种状况下，市场变成了“赌场”，虽然遍地都是交易的机会，动不动百分之十几的震荡，赚钱的难度远高于以往。 就在这个市场唯一主题是特朗普推特的时候，台积电召开了2025Q1业绩会，向整个美股传达了坚定的信念： AI带来的基本面大繁荣没有消散。 据台积电预计，2025年全年公司以美元计算的增速为25%，仍然维持在“关税战”爆发前所预测的水平；Q2公司的收入将会受益于3nm和5nm制程工艺的强劲增长，达到284亿美元至292亿美元之间，环比增速将达到13%，同比增速约40%，大幅超越华尔街的一致预期。 这种乐观的预期和心态，和现如今风雨飘摇的全球市场形成了格外鲜明的对比。甚至，在特朗普关税开始征收之前，当Deepseek横空出世之后，市场就开始怀疑微软、谷歌这些巨头是否会在2025年缩减购买英伟达高算力芯片的预算，而英伟达正是台积电继苹果之后的最大客户，一旦英伟达收入被影响，会直接拉低台积电的业绩。 公司CEO则在业绩会上明确表示，公司明白关税政策的潜在影响存在不确定性和风险，可到目前为止还没有看到客户行为有任何变化。但在我们看来，无论高管说什么都不重要，现在的市场关键还是关税，即便是台积电自己的业绩，也极大依赖于特朗普未来的选择。 现实情况是，特朗普针对中国特供的H20芯片禁令加码，对于英伟达生产的H20芯片以及达到H20内存带宽、互联带宽的其他芯片，若出口到中国等国家和地区需要获得许可证，且该许可证要求将无限期生效。 北京时间4月17日下午，英伟达CEO黄仁勋来到北京，开启他的系列访问，这是短短四个月内他第二次来到中国。和上一次全程松弛相比，这次","text":"最近这一个月，你周围有多少投资者还高频关注AI？想必已所剩无几了吧。 在那个疯狂的特朗普开始向全世界“征税”之后，全球股市的涨跌几乎只系于一人之言，什么AI应用、比特币等等，这些盛极一时的题材无论基本面如何，该跌的时候是几乎没有底线。在这种状况下，市场变成了“赌场”，虽然遍地都是交易的机会，动不动百分之十几的震荡，赚钱的难度远高于以往。 就在这个市场唯一主题是特朗普推特的时候，台积电召开了2025Q1业绩会，向整个美股传达了坚定的信念： AI带来的基本面大繁荣没有消散。 据台积电预计，2025年全年公司以美元计算的增速为25%，仍然维持在“关税战”爆发前所预测的水平；Q2公司的收入将会受益于3nm和5nm制程工艺的强劲增长，达到284亿美元至292亿美元之间，环比增速将达到13%，同比增速约40%，大幅超越华尔街的一致预期。 这种乐观的预期和心态，和现如今风雨飘摇的全球市场形成了格外鲜明的对比。甚至，在特朗普关税开始征收之前，当Deepseek横空出世之后，市场就开始怀疑微软、谷歌这些巨头是否会在2025年缩减购买英伟达高算力芯片的预算，而英伟达正是台积电继苹果之后的最大客户，一旦英伟达收入被影响，会直接拉低台积电的业绩。 公司CEO则在业绩会上明确表示，公司明白关税政策的潜在影响存在不确定性和风险，可到目前为止还没有看到客户行为有任何变化。但在我们看来，无论高管说什么都不重要，现在的市场关键还是关税，即便是台积电自己的业绩，也极大依赖于特朗普未来的选择。 现实情况是，特朗普针对中国特供的H20芯片禁令加码，对于英伟达生产的H20芯片以及达到H20内存带宽、互联带宽的其他芯片，若出口到中国等国家和地区需要获得许可证，且该许可证要求将无限期生效。 北京时间4月17日下午，英伟达CEO黄仁勋来到北京，开启他的系列访问，这是短短四个月内他第二次来到中国。和上一次全程松弛相比，这次","images":[{"img":"https://static.tigerbbs.com/dd58579cce549327c1328f70c0c46976","width":"1080","height":"617"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/425736670114544","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":879,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":467892285927640,"gmtCreate":1755249073740,"gmtModify":1755249075004,"author":{"id":"4130491029501360","authorId":"4130491029501360","name":"甜甜小","avatar":"https://static.tigerbbs.com/25fc231df4362a5cdc318177a8de3233","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4130491029501360","authorIdStr":"4130491029501360"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02076\">$BOSS直聘-W(02076)$</a> <a href=\"https://laohu8.com/S/BZ\">$BOSS直聘(BZ)$</a> 从行业前景到企业自身经营数据，多维度呈现向好态势，BOSS直聘的成长逻辑有很强的可验证性","listText":"<a href=\"https://laohu8.com/S/02076\">$BOSS直聘-W(02076)$</a> <a href=\"https://laohu8.com/S/BZ\">$BOSS直聘(BZ)$</a> 从行业前景到企业自身经营数据，多维度呈现向好态势，BOSS直聘的成长逻辑有很强的可验证性","text":"$BOSS直聘-W(02076)$ $BOSS直聘(BZ)$ 从行业前景到企业自身经营数据，多维度呈现向好态势，BOSS直聘的成长逻辑有很强的可验证性","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/467892285927640","isVote":1,"tweetType":1,"viewCount":140,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":462469567807920,"gmtCreate":1753926472111,"gmtModify":1753926951180,"author":{"id":"4130491029501360","authorId":"4130491029501360","name":"甜甜小","avatar":"https://static.tigerbbs.com/25fc231df4362a5cdc318177a8de3233","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4130491029501360","authorIdStr":"4130491029501360"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02590\">$极智嘉-W(02590)$</a> 极智嘉获YesAsia复购，成为香港规模最大的 AMR机器人智能仓，我不信业务增长你股价能一直跌。","listText":"<a href=\"https://laohu8.com/S/02590\">$极智嘉-W(02590)$</a> 极智嘉获YesAsia复购，成为香港规模最大的 AMR机器人智能仓，我不信业务增长你股价能一直跌。","text":"$极智嘉-W(02590)$ 极智嘉获YesAsia复购，成为香港规模最大的 AMR机器人智能仓，我不信业务增长你股价能一直跌。","images":[{"img":"https://static.tigerbbs.com/2225a737cfd9e6798ca05d3cc4b8132e","width":"1236","height":"597"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/462469567807920","isVote":1,"tweetType":1,"viewCount":405,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":454284342829264,"gmtCreate":1751939808749,"gmtModify":1751939820048,"author":{"id":"4130491029501360","authorId":"4130491029501360","name":"甜甜小","avatar":"https://static.tigerbbs.com/25fc231df4362a5cdc318177a8de3233","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4130491029501360","authorIdStr":"4130491029501360"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/09678\">$云知声(09678)$</a> 上次跌到300块我果断加仓，感谢自己没被洗下车，这波看到500港元","listText":"<a href=\"https://laohu8.com/S/09678\">$云知声(09678)$</a> 上次跌到300块我果断加仓，感谢自己没被洗下车，这波看到500港元","text":"$云知声(09678)$ 上次跌到300块我果断加仓，感谢自己没被洗下车，这波看到500港元","images":[{"img":"https://static.tigerbbs.com/3c8a7d3e2f3eabe69efd62831322f2b2","width":"1080","height":"2376"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/454284342829264","isVote":1,"tweetType":1,"viewCount":405,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":444780383171168,"gmtCreate":1749610019172,"gmtModify":1749610020907,"author":{"id":"4130491029501360","authorId":"4130491029501360","name":"甜甜小","avatar":"https://static.tigerbbs.com/25fc231df4362a5cdc318177a8de3233","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4130491029501360","authorIdStr":"4130491029501360"},"themes":[],"htmlText":"发现现在药企都在卷双抗，维立志博这个PD-L1/4-1BB双抗是全球首个进注册临床的4-1BB靶向药，先发已经优势有了","listText":"发现现在药企都在卷双抗，维立志博这个PD-L1/4-1BB双抗是全球首个进注册临床的4-1BB靶向药，先发已经优势有了","text":"发现现在药企都在卷双抗，维立志博这个PD-L1/4-1BB双抗是全球首个进注册临床的4-1BB靶向药，先发已经优势有了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/444780383171168","isVote":1,"tweetType":1,"viewCount":447,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":444462053658920,"gmtCreate":1749532544797,"gmtModify":1749533016597,"author":{"id":"4130491029501360","authorId":"4130491029501360","name":"甜甜小","avatar":"https://static.tigerbbs.com/25fc231df4362a5cdc318177a8de3233","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4130491029501360","authorIdStr":"4130491029501360"},"themes":[],"htmlText":"在创新药投资中，高风险常被挂在嘴边，看了下维立志博的几个管线，安全性优势很突出，这对后续商业化至关重要，毕竟医生更愿意用副作用小的药，在管线布局上，也都踩在临床刚需和竞争较少的痛点上，这点还是不错的","listText":"在创新药投资中，高风险常被挂在嘴边，看了下维立志博的几个管线，安全性优势很突出，这对后续商业化至关重要，毕竟医生更愿意用副作用小的药，在管线布局上，也都踩在临床刚需和竞争较少的痛点上，这点还是不错的","text":"在创新药投资中，高风险常被挂在嘴边，看了下维立志博的几个管线，安全性优势很突出，这对后续商业化至关重要，毕竟医生更愿意用副作用小的药，在管线布局上，也都踩在临床刚需和竞争较少的痛点上，这点还是不错的","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/444462053658920","isVote":1,"tweetType":1,"viewCount":468,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":427196267896928,"gmtCreate":1745319812685,"gmtModify":1745326603450,"author":{"id":"4130491029501360","authorId":"4130491029501360","name":"甜甜小","avatar":"https://static.tigerbbs.com/25fc231df4362a5cdc318177a8de3233","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4130491029501360","authorIdStr":"4130491029501360"},"themes":[],"htmlText":"老厉害了","listText":"老厉害了","text":"老厉害了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/427196267896928","repostId":"427088858517752","repostType":1,"repost":{"id":427088858517752,"gmtCreate":1745292934673,"gmtModify":1746577348014,"author":{"id":"3586209944041237","authorId":"3586209944041237","name":"静待花开的小C","avatar":"https://static.tigerbbs.com/4befb19561784346ee300c191ae4c5f2","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586209944041237","authorIdStr":"3586209944041237"},"themes":[],"htmlText":"我开仓了<a href=\"https://laohu8.com/S/SOXL\">$三倍做多半导体ETF-Direxion Daily(SOXL)$&nbsp;</a>,半导体调整太大，英伟达也扛不住。这个位置买入风险没这么大了。","listText":"我开仓了<a href=\"https://laohu8.com/S/SOXL\">$三倍做多半导体ETF-Direxion Daily(SOXL)$&nbsp;</a>,半导体调整太大，英伟达也扛不住。这个位置买入风险没这么大了。","text":"我开仓了$三倍做多半导体ETF-Direxion Daily(SOXL)$ ,半导体调整太大，英伟达也扛不住。这个位置买入风险没这么大了。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/427088858517752","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":910,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":425753291084000,"gmtCreate":1744966867999,"gmtModify":1744966948024,"author":{"id":"4130491029501360","authorId":"4130491029501360","name":"甜甜小","avatar":"https://static.tigerbbs.com/25fc231df4362a5cdc318177a8de3233","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4130491029501360","authorIdStr":"4130491029501360"},"themes":[],"htmlText":"[贱笑]","listText":"[贱笑]","text":"[贱笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/425753291084000","repostId":"425736670114544","repostType":1,"repost":{"id":425736670114544,"gmtCreate":1744963445907,"gmtModify":1744964286404,"author":{"id":"3526437230772528","authorId":"3526437230772528","name":"躺平指数","avatar":"https://static.tigerbbs.com/c500a27501e73e9bde05437de1974e50","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3526437230772528","authorIdStr":"3526437230772528"},"themes":[],"title":"AI没落？台积电业绩力证繁荣仍在，却难扫关税阴霾","htmlText":"最近这一个月，你周围有多少投资者还高频关注AI？想必已所剩无几了吧。 在那个疯狂的特朗普开始向全世界“征税”之后，全球股市的涨跌几乎只系于一人之言，什么AI应用、比特币等等，这些盛极一时的题材无论基本面如何，该跌的时候是几乎没有底线。在这种状况下，市场变成了“赌场”，虽然遍地都是交易的机会，动不动百分之十几的震荡，赚钱的难度远高于以往。 就在这个市场唯一主题是特朗普推特的时候，台积电召开了2025Q1业绩会，向整个美股传达了坚定的信念： AI带来的基本面大繁荣没有消散。 据台积电预计，2025年全年公司以美元计算的增速为25%，仍然维持在“关税战”爆发前所预测的水平；Q2公司的收入将会受益于3nm和5nm制程工艺的强劲增长，达到284亿美元至292亿美元之间，环比增速将达到13%，同比增速约40%，大幅超越华尔街的一致预期。 这种乐观的预期和心态，和现如今风雨飘摇的全球市场形成了格外鲜明的对比。甚至，在特朗普关税开始征收之前，当Deepseek横空出世之后，市场就开始怀疑微软、谷歌这些巨头是否会在2025年缩减购买英伟达高算力芯片的预算，而英伟达正是台积电继苹果之后的最大客户，一旦英伟达收入被影响，会直接拉低台积电的业绩。 公司CEO则在业绩会上明确表示，公司明白关税政策的潜在影响存在不确定性和风险，可到目前为止还没有看到客户行为有任何变化。但在我们看来，无论高管说什么都不重要，现在的市场关键还是关税，即便是台积电自己的业绩，也极大依赖于特朗普未来的选择。 现实情况是，特朗普针对中国特供的H20芯片禁令加码，对于英伟达生产的H20芯片以及达到H20内存带宽、互联带宽的其他芯片，若出口到中国等国家和地区需要获得许可证，且该许可证要求将无限期生效。 北京时间4月17日下午，英伟达CEO黄仁勋来到北京，开启他的系列访问，这是短短四个月内他第二次来到中国。和上一次全程松弛相比，这次","listText":"最近这一个月，你周围有多少投资者还高频关注AI？想必已所剩无几了吧。 在那个疯狂的特朗普开始向全世界“征税”之后，全球股市的涨跌几乎只系于一人之言，什么AI应用、比特币等等，这些盛极一时的题材无论基本面如何，该跌的时候是几乎没有底线。在这种状况下，市场变成了“赌场”，虽然遍地都是交易的机会，动不动百分之十几的震荡，赚钱的难度远高于以往。 就在这个市场唯一主题是特朗普推特的时候，台积电召开了2025Q1业绩会，向整个美股传达了坚定的信念： AI带来的基本面大繁荣没有消散。 据台积电预计，2025年全年公司以美元计算的增速为25%，仍然维持在“关税战”爆发前所预测的水平；Q2公司的收入将会受益于3nm和5nm制程工艺的强劲增长，达到284亿美元至292亿美元之间，环比增速将达到13%，同比增速约40%，大幅超越华尔街的一致预期。 这种乐观的预期和心态，和现如今风雨飘摇的全球市场形成了格外鲜明的对比。甚至，在特朗普关税开始征收之前，当Deepseek横空出世之后，市场就开始怀疑微软、谷歌这些巨头是否会在2025年缩减购买英伟达高算力芯片的预算，而英伟达正是台积电继苹果之后的最大客户，一旦英伟达收入被影响，会直接拉低台积电的业绩。 公司CEO则在业绩会上明确表示，公司明白关税政策的潜在影响存在不确定性和风险，可到目前为止还没有看到客户行为有任何变化。但在我们看来，无论高管说什么都不重要，现在的市场关键还是关税，即便是台积电自己的业绩，也极大依赖于特朗普未来的选择。 现实情况是，特朗普针对中国特供的H20芯片禁令加码，对于英伟达生产的H20芯片以及达到H20内存带宽、互联带宽的其他芯片，若出口到中国等国家和地区需要获得许可证，且该许可证要求将无限期生效。 北京时间4月17日下午，英伟达CEO黄仁勋来到北京，开启他的系列访问，这是短短四个月内他第二次来到中国。和上一次全程松弛相比，这次","text":"最近这一个月，你周围有多少投资者还高频关注AI？想必已所剩无几了吧。 在那个疯狂的特朗普开始向全世界“征税”之后，全球股市的涨跌几乎只系于一人之言，什么AI应用、比特币等等，这些盛极一时的题材无论基本面如何，该跌的时候是几乎没有底线。在这种状况下，市场变成了“赌场”，虽然遍地都是交易的机会，动不动百分之十几的震荡，赚钱的难度远高于以往。 就在这个市场唯一主题是特朗普推特的时候，台积电召开了2025Q1业绩会，向整个美股传达了坚定的信念： AI带来的基本面大繁荣没有消散。 据台积电预计，2025年全年公司以美元计算的增速为25%，仍然维持在“关税战”爆发前所预测的水平；Q2公司的收入将会受益于3nm和5nm制程工艺的强劲增长，达到284亿美元至292亿美元之间，环比增速将达到13%，同比增速约40%，大幅超越华尔街的一致预期。 这种乐观的预期和心态，和现如今风雨飘摇的全球市场形成了格外鲜明的对比。甚至，在特朗普关税开始征收之前，当Deepseek横空出世之后，市场就开始怀疑微软、谷歌这些巨头是否会在2025年缩减购买英伟达高算力芯片的预算，而英伟达正是台积电继苹果之后的最大客户，一旦英伟达收入被影响，会直接拉低台积电的业绩。 公司CEO则在业绩会上明确表示，公司明白关税政策的潜在影响存在不确定性和风险，可到目前为止还没有看到客户行为有任何变化。但在我们看来，无论高管说什么都不重要，现在的市场关键还是关税，即便是台积电自己的业绩，也极大依赖于特朗普未来的选择。 现实情况是，特朗普针对中国特供的H20芯片禁令加码，对于英伟达生产的H20芯片以及达到H20内存带宽、互联带宽的其他芯片，若出口到中国等国家和地区需要获得许可证，且该许可证要求将无限期生效。 北京时间4月17日下午，英伟达CEO黄仁勋来到北京，开启他的系列访问，这是短短四个月内他第二次来到中国。和上一次全程松弛相比，这次","images":[{"img":"https://static.tigerbbs.com/dd58579cce549327c1328f70c0c46976","width":"1080","height":"617"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/425736670114544","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":3,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":879,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}